Annual Revenue
N/A
December 31, 2023
Summary
- MACK annual revenue is not available.
Performance
MACK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Revenue
N/A
March 1, 2024
Summary
- MACK quarterly revenue is not available.
Performance
MACK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
March 1, 2024
Summary
- MACK TTM revenue is not available.
Performance
MACK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
MACK Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MACK Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Merrimack Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | -$67.84 M(-512.6%) | $1000.00(-100.0%) |
| Sep 2015 | - | $16.44 M(-55.0%) | $101.75 M(-10.2%) |
| Jun 2015 | - | $36.56 M(+146.3%) | $113.31 M(+8.4%) |
| Mar 2015 | - | $14.84 M(-56.2%) | $104.56 M(+1.8%) |
| Dec 2014 | $102.76 M(+115.0%) | $33.91 M(+21.1%) | $102.76 M(+34.0%) |
| Sep 2014 | - | $28.00 M(+0.7%) | $76.67 M(+38.1%) |
| Jun 2014 | - | $27.82 M(+113.4%) | $55.53 M(+20.3%) |
| Mar 2014 | - | $13.03 M(+66.6%) | $46.16 M(-3.4%) |
| Dec 2013 | $47.79 M(-2.3%) | $7.82 M(+14.1%) | $47.79 M(-11.8%) |
| Sep 2013 | - | $6.86 M(-62.8%) | $54.15 M(-7.6%) |
| Jun 2013 | - | $18.45 M(+25.9%) | $58.62 M(+12.2%) |
| Mar 2013 | - | $14.65 M(+3.3%) | $52.23 M(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $48.92 M(+43.0%) | $14.19 M(+25.3%) | $48.92 M(+3.4%) |
| Sep 2012 | - | $11.32 M(-6.1%) | $47.31 M(+6.2%) |
| Jun 2012 | - | $12.06 M(+6.3%) | $44.57 M(+14.0%) |
| Mar 2012 | - | $11.34 M(-9.8%) | $39.10 M(+14.3%) |
| Dec 2011 | $34.22 M(+68.5%) | $12.58 M(+46.6%) | $34.22 M(+22.4%) |
| Sep 2011 | - | $8.58 M(+30.1%) | $27.95 M(+11.4%) |
| Jun 2011 | - | $6.59 M(+2.1%) | $25.10 M(+10.1%) |
| Mar 2011 | - | $6.46 M(+2.4%) | $22.80 M(+12.3%) |
| Dec 2010 | $20.30 M(+845.3%) | $6.31 M(+10.0%) | $20.30 M(+45.1%) |
| Sep 2010 | - | $5.73 M(+33.5%) | $14.00 M(+69.4%) |
| Jun 2010 | - | $4.29 M(+8.2%) | $8.26 M(+108.2%) |
| Mar 2010 | - | $3.97 M | $3.97 M |
| Dec 2009 | $2.15 M | - | - |
FAQ
- What is the all time high annual revenue for Merrimack Pharmaceuticals?
- What is the all time high quarterly revenue for Merrimack Pharmaceuticals?
- What is the all time high TTM revenue for Merrimack Pharmaceuticals?
What is the all time high annual revenue for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual revenue is $102.76 M
What is the all time high quarterly revenue for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly revenue is $36.56 M
What is the all time high TTM revenue for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high TTM revenue is $113.31 M